Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01693055
Other study ID # E-1207/162-004
Secondary ID L-2012-408-3
Status Completed
Phase N/A
First received September 18, 2012
Last updated April 4, 2014
Start date September 2012
Est. completion date February 2013

Study information

Verified date April 2014
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Study title

- Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid Study design

- single arm and Investigator Initiative pilot study


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date February 2013
Est. primary completion date February 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Age >20 years, Age < 50 years

- people who want to improve baggy eyelid

- Information consent obtained

Exclusion Criteria:

- previous lower eyelid surgical history

- scar on lower eyelid after trauma

- bleeding tendency

- aesthetic addiction, drug abuse, alcohol abuse

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
UltheraTM 100 shots
UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe

Locations

Country Name City State
Korea, Republic of Seoul National Univ. Bundang Hospital, Gumi-dong, Bundang-gu Seongnam-si, Gyeonggi-do

Sponsors (2)

Lead Sponsor Collaborator
Seoul National University Hospital Ulthera, Inc

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary The distance from the inferior orbital rim to the skin Difference between the distance ( from the inferior orbital rim to the skin) measured by orbital CT at Screening and 12weeks after UltheraTM treatment Change from Screening in distance at 12weeks after Ulthera treatment Yes
Secondary The distance from the most protrusive baggy eyelid to the orbital septum The distance(mm),from the most protrusive baggy eyelid to the orbital septum will be measured by a plastic surgeon with orbital CT films. Each participant will do Orbital CT scan 2 times, at screening and 12weeks after treatment Change from Screening in distance at 12weeks after UltheraTM treatment No
Secondary Subject Satisfaction for baggy lower eyelid 5-point scale for Subject Satisfaction in baggy lower eyelid. The subject satisfaction is calculated as a score between 0 and 4( 0= very poor, 4= very good). Change from Screening in satisfaction at 4 weeks and 12weeks No
Secondary Improvement of baggy lower eyelid Improvement of baggy lower eyelid will be assessed by Two plastic surgeons. Both assessors will evaluate Improvement of baggy lower eyelid including skin laxity and orbital fat prolapse using 5-point scale.
0= no involvement
mild
moderate
marked
severe
Change from Screening in baggy lower eyelid at 12weeks after UltheraTM treatment No